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Abstract
Background: The purpose of this study was to examine the effect of a pre-exercise high energy drink on
reaction time and anaerobic power in competitive strength/power athletes. In addition, the effect of the
pre-exercise drink on subjective feelings of energy, fatigue, alertness and focus was also explored.
Methods: Twelve male strength/power athletes (21.1 ± 1.3 y; 179.8 ± 7.1 cm; 88.6 ± 12.1 kg; 17.6 ± 3.3%
body fat) underwent two testing sessions administered in a randomized and double-blind fashion. During
each session, subjects reported to the Human Performance Laboratory and were provided with either 120
ml of a high energy drink (SUP), commercially marketed as Redline Extreme® or 120 ml of a placebo (PL)
that was similar in taste and appearance but contained no active ingredients. Following consumption of the
supplement or placebo subjects rested quietly for 10-minutes prior to completing a survey and
commencing exercise. The survey consisted of 4 questions asking each subject to describe their feelings
of energy, fatigue, alertness and focus for that moment. Following the completion of the questionnaire
subjects performed a 2-minute quickness and reaction test on the Makoto testing device (Makoto USA,
Centennial CO) and a 20-second Wingate Anaerobic Power test. Following a 10-minute rest subjects
repeated the testing sequence and after a similar rest period a third and final testing sequence was
performed. The Makoto testing device consisted of subjects reacting to both a visual and auditory stimulus
and striking one out of 30 potential targets on three towers.
Results: Significant difference in reaction performance was seen between SUP and PL in both average
number of targets struck (55.8 ± 7.4 versus 51.9 ± 7.4, respectively) and percent of targets struck (71.9 ±
10.5% versus 66.8 ± 10.9%, respectively). No significant differences between trials were seen in any
anaerobic power measure. Subjective feelings of energy (3.5 ± 0.5 versus 3.1 ± 0.5) and focus (3.8 ± 0.5
versus 3.3 ± 0.7) were significantly higher during SUP compared to PL, respectively. In addition, a trend
towards an increase in average alertness (p = 0.06) was seen in SUP compared to P.
Conclusion: Results indicate a significant increase in reaction performance, with no effect on anaerobic
power performance. In addition, ingestion of this supplement significantly improves subjective feelings of
focus and energy in male strength/power athletes.
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High energy drinks and capsules have recently been
shown to be the most popular supplement besides multi-
vitamins in the American adolescent and young adult
population [1,2]. More than 30% of all American male
and female adolescents are reported to use these supple-
ments on a regular basis. The primary reason for use of
these supplements is thought to be related to their desire
to reduce or control body fat [1-4]. However, many ath-
letes use these high energy supplements for its potential
ergogenic effect. They believe that using high energy sup-
plements prior to performance will result in greater focus,
reaction time and power. Unfortunately, most informa-
tion available is based upon empirical evidence.
Several papers have been published showing that a pre-
exercise, high energy supplement can delay fatigue and/or
improve the quality of a resistance training workout [5-7].
A recent study showed that a pre-exercise high energy sup-
plement consumed 10 minutes before resistance exercise
can enhance acute exercise performance by increasing the
number of repetitions performed and the total volume of
exercise [7]. The enhanced exercise performance resulted
in a significantly greater increase in both growth hormone
and insulin concentrations, indicating an augmented ana-
bolic hormone response to this pre-exercise supplement.
Although the ergogenic benefits associated with high
energy supplements have been demonstrated, the ability
to improve subjective feelings of focus, awareness or
improve reaction time is not clear. Anecdotal reports sug-
gest that many athletes use high energy supplements prior
to an athletic contest to enhance these specific compo-
nents. However, studies examining the ability of these
pre-exercise energy supplements to improve reaction time
and performance are scarce.
Many pre-exercise high energy supplements consist of
multiple ingredients that are proposed to either increase
metabolic rate, enhance exercise performance or both.
One such supplement is known as Redline Extreme™. It
consists of various herbal and amino acid ingredients
which include evodiamine, vinpocetine, yohimbine,
hordenine, salbutiamine, beta-alanine, tyrosine, and
tyramine. These herbs and amino acids are suggested to
work synergistically to enhance exercise performance.
Thus, it is the purpose of this study to examine the effect
of a popular, over-the-counter high energy supplement on
physical performance and subjective feelings of energy,
focus, awareness and fatigue in strength/power athletes.
Methods
Subjects
Twelve male strength/power athletes (mean ± SD; 21.1 ±
1.3 y; 179.8 ± 7.1 cm; 88.6 ± 12.1 kg; 17.6 ± 3.3% body
fat) volunteered for this study. Following an explanation
of all procedures, risks and benefits each subject gave his
written informed consent to participate in this study. The
Institutional Review Board of The College of New Jersey
approved the research protocol. Subjects with any known
metabolic or cardiovascular disease, or psychiatric disor-
der were excluded. Subjects were also required to have
been free of any nutritional supplements or ergogenic aids
for the 6 weeks preceding the study, and were asked to
refrain from taking any additional supplement during the
duration of the study.
Study design
The study followed a randomized double-blind, crossover
design. Subjects reported to the Human Performance Lab-
oratory on two separate days. Each testing session was sep-
arated by one week. Subjects were instructed to refrain
from consuming any caffeine products on the day of each
testing session and from performing any strenuous physi-
cal activity for the previous 12 hours. In addition, subjects
were instructed not to eat or drink for 3 hours prior to
each trial. Following a 10 min resting period subjects were
randomly provided with either the supplement (SUP) or
the placebo (PL). On the subject's second visit to the lab-
oratory they were provided with the opposite treatment.
Following consumption of the supplement or placebo
subjects, rested quietly for 10-minutes prior to completing
a survey and commencing exercise (T1). The survey con-
sisted of 4 questions asking each subject to describe their
feelings of energy, fatigue, alertness and focus for that
moment. Following the completion of the questionnaire
subjects performed a 2-minute quickness and reaction test
on the Makoto testing device (Makoto USA, Centennial
CO) and a 20-second Wingate Anaerobic Power test. Fol-
lowing a 10-minute rest subjects repeated the testing
sequence (T2) and after a similar rest period a third and
final testing sequence was performed (T3). The study pro-
tocol is depicted in Figure 1.
Reaction test
The measure of reaction time was assessed using the
Makoto testing device (Makoto USA, Centennial CO). The
Makoto device is in the shape of a triangle that is eight feet
from base to apex (see Figure 2). It consists of three steel
towers that are six feet high. Each tower contains ten tar-
gets. For each test the subject stood in the middle of the
triangle holding a padded staff with both hands and faced
one of the towers with the other two in his peripheral
vision. The reaction test began with a loud auditory stim-
ulus. During the next two minutes subjects were required
to react to both a visual (targets light up) and auditory
(loud gong) stimulus. As the gong sounded and the light
on the target lit up the subject was required to lunge and
make contact with the target using the staff. Subjects had
to make contact to the target prior to the light and soundPage 2 of 8
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within the required time it was registered as a 'hit'. Sub-
jects were required to make as many contacts as possible
within the 2-min period. A total of three trials were con-
ducted (one trial during each 10 min period) and the aver-
age number of hits was determined and the average
percentage of hits [(successful contacts/total number of
possible stimuli)*100] was calculated.
The Makoto testing device has 12 levels of skill. All tests
for this study were conducted at the highest level (level
12). All subjects completed familiarization sessions prior
to entering the study. All familiarization sessions started
at level 7. To advance to the next level subjects needed to
be within 10% of their score for two consecutive trials
(plateau effect). Advancements were made two levels at a
time. For instance, subjects performed familiarization ses-
sions at levels 7, 9 and 11. Subjects performed on average
9.5 ± 1.9 familiarization sessions.
Anaerobic power measure
To quantify anaerobic power performance all subjects per-
formed a modified Wingate anaerobic power test (Lode
Excalibur, Groningen, The Netherlands). After a warm-up
period of 5 min of pedaling at 60 rpm interspersed with
an all-out sprint lasting 5 s, the subjects pedaled for 20 s
at maximal speed against a constant force (1.2 Nm·kg-1).
Peak power, mean power, time to peak power, total work
and a fatigue index was determined. Peak power was
defined as the highest mechanical power output elicited
during the test. Mean power was defined as the average
mechanical power during the 20 s test. The fatigue index
was determined by dividing the highest power output by
the lowest power output. A total of three 20-s Wingate
tests (one Wingate test per 10-min period) were per-
formed during each trial and measures were averaged over
the three sprints.
Study ProtocolFigure 1
Study Protocol. WAnt = Wingate Anaerobic Power Test.Page 3 of 8
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Prior to each bout of performance measures subjects were
asked to complete a questionnaire containing four ques-
tions using a 5-point rating scale. Subjects were asked to
rate their energy level, fatigue level, feelings of alertness
and feelings of focus for task using the following verbal
anchors: 1 = very low; 2 = low; 3 = average; 4 = high; 5 =
very high. The same researcher performed all test admin-
istrations and tests were conducted under controlled con-
ditions (a quiet room). The average response of the three
testing sessions was computed.
Supplement
On each visit subjects consumed 120 ml of the ready to
drink supplement or placebo. The supplement used is
marketed as Redline Extreme® (Vital Pharmaceuticals,
Davie, FL) and contains caffeine anhydrous, beta-alanine,
vitamin C, and the following herbal and botanical com-
pounds; evodiamine, N-acetyl-L-tyrosine, hordenine, 5-
hydroxytryptophan, potassium citrate, N-methyl
tyramine, sulbutiamine, vinpocetine, yohimbine HCL,
and St. John's wort extract. The placebo was similar in
appearance and taste to Redline Extreme®, but contained
only an inert substance.
Statistical analyses
Statistical analysis of the data was accomplished using a
repeated measures analysis of variance. In the event of a
significant F-ratio, LSD post-hoc tests were used for pair-
wise comparisons. Comparisons of the average perform-
ance measures for the three testing periods were analyzed
using paired student's T-tests. A criterion alpha level of p
≤ 0.05 was used to determine statistical significance. All
data are reported as mean ± SD.
Results
The responses to the questionnaire can be seen in Table 1.
The average energy level during the three testing periods
was significantly higher for SUP than PL. In addition,
focus for task was significantly greater at T3 for SUP than
PL, and the average focus for task for all three testing peri-
ods combined was significantly higher for SUP than PL.
Average feelings of alertness tended to be higher (p <
0.06) for SUP than PL. No significant differences in per-
ceived levels of fatigue were seen between the groups.
The anaerobic power measures are depicted in Table 2. No
between group differences in any performance measure
were seen at any testing period and no differences in the
average performance measure were seen between SUP and
PL. Significant differences in reaction time were seen
between the groups. The average number of successful hits
to target was significantly higher for SUP than PL (see Fig-
ure 3a), and the average percentage of successful hits on
target was also significantly greater for SUP than PL (see
Figure 3b)
Discussion
The results of this study indicate that a pre-exercise energy
drink containing anhydrous caffeine, beta-alanine, vita-
min C, evodiamine, N-acetyl-L-tyrosine, hordenine, 5-
hydroxytryptophan, potassium citrate, N-methyl
tyramine, sulbutiamine, vinpocetine, yohimbine HCL,
and St. John's wort extract can significantly improve reac-
tion time and enhance self-perceived feelings of energy
and focus. In addition, a trend towards improved alert-
ness in subjects using this supplement versus placebo was
also seen. Supplement ingestion did not have any ergo-
genic benefit for anaerobic power performance.
Caffeine is a mild central nervous system stimulant,
whose effects are similar to those associated with amphet-
amines, only much weaker [8]. It has been used as an
ergogenic aid for many years, but consistent benefits have
only been seen during exhaustive endurance exercise in
which time to exhaustion is often improved [5,9-11]. This
is thought to be related to caffeine's ability to enhance
Makoto Testing DeviceFigure 2
Makoto Testing Device.Page 4 of 8
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tent [12]. Although caffeine has been suggested to aug-
ment strength and power performance by enhancing
excitation – contraction coupling during neuromuscular
transmission through mobilizing intracellular calcium
ions from the sarcoplasmic reticulum [13] and/or by
enhancing the kinetics of glycolytic regulatory enzymes
such as phosphorylase [12], evidence demonstrating its
ergogenic benefit during anaerobic performance is lim-
ited.
To maximize the effectiveness of caffeine, supplements
often contain several ingredients that attempt to exacer-
bate its stimulatory potential. The combination of ephe-
dra and caffeine had been shown to be an effective
ergogenic aid [14], however, the multitude of adverse
events associated with ephedra led to this supplement
being removed from the sport supplement market
[15,16]. As a result, other ingredients that stimulate β-
adrenergic receptors albeit with a lower risk for adverse
events have been combined with caffeine with the desire
to enhance athletic performance either by improving met-
abolic or muscle contraction efficiency, or perhaps by
enhancing subjective feelings of energy, focus or aware-
ness. The results of this study indicate that the combina-
tion of ingredients comprising Redline Extreme™ were
effective in providing a greater stimulatory response as
reflected by higher self-perceived levels of focus, energy
and awareness and an enhanced reaction to visual and
audio stimuli. The combination of these stimulatory
ingredients though was unable to augment anaerobic
power performance.
The combination of yohimbine, evodiamine, hordenine,
tyramine, tyrosine and caffeine appear to be the primary
ingredients providing the stimulatory effect from Redline
Extreme®. Yohimbine is a selective α-adrenoceptor antag-
onist that is also reported to be effective in enhancing
lipid metabolism [17,18]. Evodiamine is a major alkaloid
from evodia fruits that has been reported to stimulate
vanilloid receptor activities comparable to capsaicin
(compound found in hot peppers) [19]. Research on evo-
diamine is limited, but it has been shown to increase core
body temperature [20]. Hordenine is also an alkaloid and
is found in grains, sprouting barley and certain grasses, as
well as in small quantities in citrus aurantium [21]. Citrus
aurantium is a mild stimulant that is often used in nutri-
tional supplements to suppress appetite and enhance met-
abolic rate [22]. Tyramine is a monoamine compound
that is derived from the amino acid tyrosine. It is an indi-
rect sympathomimetic, meaning that it does not directly
activate adrenergic receptors, but acts as a substrate for
adrenergic uptake systems and monoamine oxidase pro-
longing the actions of adrenergic transmitters [23]. Tyro-
sine is a precursor for the synthesis of dopamine and
norepinephrine [24]. Its role is to enhance neurotransmit-
ter synthesis that has important β-adrenergic stimulatory
effect. Although the combination of these compounds in
this supplement appears to be effective in producing the
stimulatory effect as demonstrated presently, the proprie-
tary nature (e.g., precise concentration of each ingredient
is not released) of this supplement limits discussion on
the possible extent of contribution from each ingredient.
Sulbutiamine is a centrally acting cholinergic agent that
has been shown to be effective in treating fatigue or cen-
tral weakness in clinical populations [25,26]. Its efficacy
Table 1: Response to performance questionnaire
Question Group T1 T2 T3 AVG
My energy level is: Sup 3.7 ± 0.7 3.5 ± 0.7 3.3 ± 0.6 3.5 ± 0.5 *
PL 3.2 ± 0.6 3.2 ± 0.6 2.8 ± 0.9 3.1 ± 0.5
My fatigue level is: Sup 2.3 ± 0.9 2.8 ± 0.8 3.1 ± 0.7 2.7 ± 0.6
PL 2.4 ± 0.7 3.1 ± 0.5 3.3 ± 0.9 2.9 ± 0.5
My feeling of alertness is: Sup 3.7 ± 0.7 3.6 ± 0.5 3.6 ± 0.7 3.6 ± 0.4
PL 3.3 ± 0.7 3.4 ± 0.7 3.1 ± 1.0 3.3 ± 0.7
My feeling of focus for task is: Sup 3.8 ± 0.7 3.8 ± 0.6 3.7 ± 0.7 * 3.8 ± 0.5 *
PL 3.3 ± 0.7 3.5 ± 0.7 3.0 ± 1.0 3.3 ± 0.7
SUP = Supplement; PL = Placebo; * = significant difference between SUP and PL. All data are reported as Mean ± SD.Page 5 of 8
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a: Reaction time: Average number of hits. * = Significant difference (p < 0.05) between the supplement and placebo. b: 
Reaction time: Average percentage of successful hits from total possible targets. * = Significant difference (p < 0.05) between 
the supplement and placebo. Data are reported mean ± SD.
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appears to be the first study to examine its efficacy for
enhancing energy in this subject population. Vinpocetine
is a derivative of vinacamine; a purified extract of Vinca
Minor L (Periwinkle plant). It has previously been used as
a cerebral vasodilator for enhancing mental alertness and
memory [27]. It is likely that the combination of these
ingredients contributed to the enhanced energy and focus
experienced by the subjects in this study.
The role that the additional ingredients in the supplement
(e.g beta-alanine, 5-hydroxytryptophan and St Johns wort
extract) may have played is not clear. Beta-alanine is a
non-proteogenic amino acid that can enhance the buffer-
ing capacity of muscle by increasing muscle carnosine
concentrations [28]. Its role as a high energy supplement
though is questionable, considering that it has no known
acute effect on metabolic rate or stimulation of adrenergic
receptors [15]. The addition of 5-hydroxytryptophan and
St John's wort extract as ingredients may be related to their
potential for mood enhancement. 5-hydroxytryptophan
is thought to enhance mood by stimulating dopamine
release [29] and enhancing serotonin production [30],
while St John's wort extract appears to act by reducing β-
adrenergic receptor binding [31]. Although mood was not
measured in this study, it is possible that these ingredients
may have influenced the stimulatory effect of this supple-
ment and contributed to the enhanced feelings of focus,
energy and awareness that subsequently enhanced reac-
tion time.
In conclusion, results of this study indicate that the sup-
plement Redline Extreme® can significantly improve sub-
jective feelings of focus and energy leading to a significant
increase in reaction time to both visual and auditory stim-
uli in strength/power athletes. However, acute ingestion
of this supplement had no effect on anaerobic power per-
formance.
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